Dopamine in Parkinson's Disease: Precise Supplementation with Motor Planning.
作者信息
Chen Leilei, Xie Junxia
机构信息
Institute of Brain Science and Disease, Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Qingdao University, Qingdao, 266071, China.
出版信息
Neurosci Bull. 2018 Oct;34(5):873-874. doi: 10.1007/s12264-018-0245-3. Epub 2018 Jun 18.
Abstract
摘要
相似文献
1
Dopamine in Parkinson's Disease: Precise Supplementation with Motor Planning.
Neurosci Bull. 2018 Oct;34(5):873-874. doi: 10.1007/s12264-018-0245-3. Epub 2018 Jun 18.
2
Conditional deletion of Ndufs4 in dopaminergic neurons promotes Parkinson's disease-like non-motor symptoms without loss of dopamine neurons.
Sci Rep. 2017 Mar 22;7:44989. doi: 10.1038/srep44989.
3
Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?
ACS Chem Neurosci. 2017 Apr 19;8(4):702-711. doi: 10.1021/acschemneuro.7b00034. Epub 2017 Mar 3.
4
Iron, Dopamine, and α-Synuclein Interactions in at-Risk Dopaminergic Neurons in Parkinson's Disease.
Neurosci Bull. 2018 Apr;34(2):382-384. doi: 10.1007/s12264-018-0209-7. Epub 2018 Jan 29.
5
Effects of striatal transplantation of cells transfected with GDNF gene without pre- and pro-regions in mouse model of Parkinson's disease.
BMC Neurosci. 2016 Jun 10;17(1):34. doi: 10.1186/s12868-016-0271-x.
6
Graded 6-OHDA-induced dopamine depletion in the nigrostriatal pathway evokes progressive pathological neuronal activities in the subthalamic nucleus of a hemi-parkinsonian mouse.
Behav Brain Res. 2018 May 15;344:42-47. doi: 10.1016/j.bbr.2018.02.014. Epub 2018 Feb 13.
7
Stress exacerbates experimental Parkinson's disease.
Mol Psychiatry. 2014 Jun;19(6):638-40. doi: 10.1038/mp.2013.108. Epub 2013 Sep 3.
8
The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.
Neuropharmacology. 2015 Oct;97:86-94. doi: 10.1016/j.neuropharm.2015.05.015. Epub 2015 May 23.
9
Effect of ghrelin on the motor deficit caused by the ablation of nigrostriatal dopaminergic cells or the inhibition of striatal dopamine receptors.
Biochem Biophys Res Commun. 2018 Feb 19;496(4):1102-1108. doi: 10.1016/j.bbrc.2018.01.145. Epub 2018 Feb 1.
10
Pitx3 deficiency produces decreased dopamine signaling and induces motor deficits in Pitx3(-/-) mice.
Neurobiol Aging. 2015 Dec;36(12):3314-3320. doi: 10.1016/j.neurobiolaging.2015.08.012. Epub 2015 Aug 20.
引用本文的文献
1
Transition metal ions and neurotransmitters: coordination chemistry and implications for neurodegeneration.
RSC Chem Biol. 2023 Jun 27;4(8):548-563. doi: 10.1039/d3cb00052d. eCollection 2023 Aug 3.
2
Corynoxine Protects Dopaminergic Neurons Through Inducing Autophagy and Diminishing Neuroinflammation in Rotenone-Induced Animal Models of Parkinson's Disease.
Front Pharmacol. 2021 Apr 13;12:642900. doi: 10.3389/fphar.2021.642900. eCollection 2021.
3
Targeting PTB as a One-Step Procedure for In Situ Astrocyte-to-Dopamine Neuron Reprogramming in Parkinson's Disease.
Neurosci Bull. 2021 Mar;37(3):430-432. doi: 10.1007/s12264-021-00630-x. Epub 2021 Jan 13.
4
Sodium Butyrate Exacerbates Parkinson's Disease by Aggravating Neuroinflammation and Colonic Inflammation in MPTP-Induced Mice Model.
Neurochem Res. 2020 Sep;45(9):2128-2142. doi: 10.1007/s11064-020-03074-3. Epub 2020 Jun 16.
5
Neuroprotective Effects of Brain-Gut Peptides: A Potential Therapy for Parkinson's Disease.
Neurosci Bull. 2019 Dec;35(6):1085-1096. doi: 10.1007/s12264-019-00407-3. Epub 2019 Jul 8.
本文引用的文献
1
Dopamine neuron activity before action initiation gates and invigorates future movements.
Nature. 2018 Feb 8;554(7691):244-248. doi: 10.1038/nature25457. Epub 2018 Jan 31.
2
Dopamine Secretion Is Mediated by Sparse Active Zone-like Release Sites.
Cell. 2018 Feb 8;172(4):706-718.e15. doi: 10.1016/j.cell.2018.01.008. Epub 2018 Feb 1.
3
Premotor Diagnosis of Parkinson's Disease.
Neurosci Bull. 2017 Oct;33(5):526-534. doi: 10.1007/s12264-017-0159-5. Epub 2017 Aug 3.
4
Clinical spectrum of levodopa-induced complications.
Mov Disord. 2015 Jan;30(1):80-9. doi: 10.1002/mds.26125. Epub 2014 Dec 8.
5
Dopamine, time, and impulsivity in humans.
J Neurosci. 2010 Jun 30;30(26):8888-96. doi: 10.1523/JNEUROSCI.6028-09.2010.
Zotero 插件